Evidence map›Paper›PMID 41298855›Full record

ArticleBone marrow transplantation2026

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Koji Kato, Yoshihiro Inamoto, Toshiro Kawakita, Yasushi Onishi, Ken-Ichi Matsuoka, Soichi Shiratori, Kazuhiro Ikegame, Nobuhiro Hiramoto, Masako Toyosaki, Yuta Katayama and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Koji KatoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. kato.koji.429@m.kyushu-u.ac.jp.ORCID http://orcid.org/0000-0002-5815-4585
Yoshihiro InamotoDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4881-0427
Toshiro KawakitaDepartment of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Yasushi OnishiDepartment of Hematology, Tohoku University Hospital, Miyagi, Japan.ORCID http://orcid.org/0000-0003-0032-6994
Ken-Ichi MatsuokaDepartment of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Soichi ShiratoriDepartment of Hematology, Hokkaido University Faculty of Medicine, Hokkaido, Japan.ORCID http://orcid.org/0000-0002-5528-7112
Kazuhiro IkegameHematopoietic Cell Transplantation Center, Aichi Medical University of School of Medicine, Aichi, Japan.
Nobuhiro HiramotoDepartment of Hematology, Kobe City Medical Center General Hospital, Hyogo, Japan.ORCID http://orcid.org/0000-0002-0472-6680
Masako ToyosakiDepartment of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan.
Yuta KatayamaDepartment of Hematology, Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan.ORCID http://orcid.org/0000-0001-5054-9104
Yuhki KogaDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Shun MurayamaMeiji Seika Pharma Co., Ltd., Tokyo, Japan.
Yuji SasagawaMeiji Seika Pharma Co., Ltd., Tokyo, Japan.
Mami ShindoMeiji Seika Pharma Co., Ltd., Tokyo, Japan.
Takanori TeshimaDepartment of Hematology, Hokkaido University Faculty of Medicine, Hokkaido, Japan.
Kiyohiko HatakeAkasaka Sanno Medical Center / Department of Hematology, Tokyo, Japan.
Yoshinobu MaedaDepartment of Hematology and Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.ORCID http://orcid.org/0000-0003-1634-5487

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41298855
PMCPMC12909102

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.